BRISTOL, Tenn., May 5 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc.
(NYSE: KG) reported today that the Company will provide a live webcast of its
conference call to be held following King's announcement of earnings for the
first quarter ending March 31, 2005. As previously announced, King plans to
announce earnings for the first quarter ending March 31, 2005, prior to the
market open on Monday, May 9, 2005.
Interested persons may listen to the conference call on Monday, May 9,
2005, at 1:00 p.m., E.D.T.
at http://www.b2i.us/external.asp?b=1084&id=153&from=wc&L=e or by dialing
800-374-1498 (US only) or 706-643-0395 (international). If you are unable to
participate during the live webcast, the call will be archived on King's web
site http://www.kingpharm.com for not less than 14 days following the call. A replay
of the conference call will also be available for not less than 5 days
following the call by dialing 800-642-1687 (US only) or 706-645-9291
(international), passcode 6068126#.
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
About Forward-Looking Statements
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated live webcast of the
Company's presentation. These forward-looking statements involve certain
significant risks and uncertainties, and actual results may differ materially
from the forward-looking statements. Some important factors which may cause
results to differ include dependence on King's ability to conduct its webcast
as currently planned on May 9, 2005. Other important factors that may cause
actual results to differ materially from the forward-looking statements are
discussed in the "Risk Factors" section and other sections of King's Form 10-K
for the year ended December 31, 2004 which is on file with the Securities and
Exchange Commission. King does not undertake to publicly update or revise any
of its forward-looking statements even if experience or future changes show
that the indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
